EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Broad‐Spectrum, Cell Envelope‐Active Marinocyclin Antibiotics From a Coral‐Derived Bacterium Are Effective Against Colistin‐Resistant Bacteria

Clara Chepkirui, Sandra Silva iD, Jan Straetener, Chandrashekhar Padhi, Tina Keller-Costa, Tess Lamer, Laura Reinke, Heike Brötz-Oesterhelt iD, Rodrigo Costa, Jörn Piel iD

Angewandte Chemie International Edition · 2026

DOI: 10.1002/anie.7705008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2026. Verfasst von Clara Chepkirui und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Microbiology, Eidgenössische Technische Hochschule (ETH) Zürich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Colistin, Drug Resistance, Bacterial, Anthozoa. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Antimicrobial Resistance, European Union's Horizon 2020, Promedica Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The marine bacterial genus Aquimarina comprises diverse members with numerous natural product biosynthetic gene clusters but few characterized compounds. Here we report a novel class of lipopeptides with exceptional antibiotic activity, named marinocyclins, isolated from Aquimarina megaterium EL43 associated with the octocoral Eunicella labiata . The major congener marinocyclin A exhibited potent and uniform activity against a broad panel of drug‐resistant gram‐negative and gram‐positive pathogens, including ESKAPE bacteria. The natural product efficiently compromised the outer and inner bacterial membranes, leading to rapid cell permeabilization and lysis. This activity profile was mediated by the ability to bind lipopolysaccharides, anionic phospholipids enriched in bacterial membranes, and peptidoglycan precursors. Eukaryotic cytotoxicity required higher doses than antibacterial activity. Genomic data suggest a nonribosomal biosynthetic origin for marinocyclins. These findings position marinocyclins as a promising new scaffold for antibiotic development and highlight the potential of Aquimarina spp. as a source of novel antibiotics. Further medicinal chemistry optimization of marinocyclins could enhance their prokaryotic selectivity to generate leads for treating infections caused by drug‐resistant pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsColistinDrug Resistance, BacterialAnthozoaGram-Negative BacteriaGram-Positive BacteriaLipopeptidesAnimalsMicrobial Sensitivity TestsCell Membrane

Stichwörter der Autor:innen

antibacterial activityantibioticsbiologymicrobiologynatural productpeptidoglycan

Substanzen

Anti-Bacterial AgentsColistinLipopeptides

Autor:innen und Institutionen

  • Institute of Microbiology, Eidgenössische Technische Hochschule (ETH) Zürich, Zurich, Switzerland.
  • iBB - Institute for Bioengineering and Biosciences and i4HB - Institute for Health and Bioeconomy, Instituto Superior Técnico, Lisbon, Portugal.
  • Department of Bioengineering, Instituto Superior Técnico, Lisbon, Portugal.
  • Interfaculty Institute of Microbiology and Infection Medicine, Microbial Bioactive Compounds, University of Tübingen, Tübingen, Germany.
  • Cluster of Excellence "Controlling Microbes to Fight Infection", Tübingen, Germany.
  • German Center for Infection Research (DZIF), Braunschweig, Germany.

ORCID-Profile: Sandra Silva, Heike Brötz-Oesterhelt, Jörn Piel

Förderung

  • Antimicrobial Resistance
  • European Union's Horizon 2020
  • Promedica Foundation
  • Portuguese Foundation for Science and Technology
  • "Fundo Azul" Programme of the Ministry of the Sea
  • Funding Scheme 5 - Capitalization and Business Innovation of the Portuguese Recovery and Resilience Plan
  • Cluster of Excellence
  • German Center for Infection Research

Zitieren

APA

Chepkirui, C., Silva, S., Straetener, J., Padhi, C., Keller-Costa, T., Lamer, T., Reinke, L., Brötz-Oesterhelt, H., Costa, R., & Piel, J. (2026). Broad‐Spectrum, Cell Envelope‐Active Marinocyclin Antibiotics From a Coral‐Derived Bacterium Are Effective Against Colistin‐Resistant Bacteria. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.7705008

Vancouver

Chepkirui C, Silva S, Straetener J, Padhi C, Keller-Costa T, Lamer T, et al. Broad‐Spectrum, Cell Envelope‐Active Marinocyclin Antibiotics From a Coral‐Derived Bacterium Are Effective Against Colistin‐Resistant Bacteria. Angewandte Chemie International Edition. 2026. doi:10.1002/anie.7705008

BibTeX
@article{Chepkirui2026,
  author = {Chepkirui, Clara and Silva, Sandra and Straetener, Jan and Padhi, Chandrashekhar and Keller-Costa, Tina and Lamer, Tess and Reinke, Laura and Brötz-Oesterhelt, Heike and Costa, Rodrigo and Piel, Jörn},
  title = {Broad‐Spectrum, Cell Envelope‐Active Marinocyclin Antibiotics From a Coral‐Derived Bacterium Are Effective Against Colistin‐Resistant Bacteria},
  journal = {Angewandte Chemie International Edition},
  year = {2026},
  doi = {10.1002/anie.7705008}
}
Kostenlos starten →